Trial intelligence / Profile preview

Enalapril After Anthracycline Cardiotoxicity

NCT00000547Phase 3Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Apr 1994
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in Cardiac dysfunction comparing Enalapril with Placebo (2 arms). Primary endpoints: Rate of decline in Maximal Cardiac Index and Rate of increase in left ventricular end systolic wall stress. Started Apr 1994; status: completed.

02

Drugs

enalapril
03

Conditions

Cardiac dysfunction

Beyond the preview

Go deeper on NCT00000547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call